l carnitine shuttle Figure 1. [The shuttle]. - GeneReviews® Carnitine Shuttle | Biochemistry

Although preclinical studies in colon cancer models show that IDO1 inhibition can enhance T cell infiltration when combined with antiCTLA-4 therapy (125, 126), clinical trials of IDO1 monotherapy have demonstrated limited efficacy (127), reflecting tumor-specific metabolic adaptations and compensatory mechanisms

[DOI] [PubMed] [Google Scholar] 224.Dimitrakopoulos S., Vitoratou S., Mougiakos T., Bogeas N., Giotakos O., van Os J., Stefanis N.C

doi: 10.1016/j.rbmo.2010.06.022 125 GovindarajuAUzunARobertsonLAtliMOKayaATopperEet al

USA 117 , 1805918067 (2020)

Vomiting episodes associated with semaglutide typically have a median duration of just 2 days, making it one of the shortest-lived common side effects